Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Therapy in Type 2 Diabetes
Pablo Aschner
American Journal of Therapeutics (2019) Vol. 27, Iss. 1, pp. e79-e90
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 10
Evidence and possible mechanisms of probiotics in the management of type 1 diabetes mellitus
Kodzovi Sylvain Dovi, Ousman Bajinka, Ishmail Conteh
Journal of Diabetes & Metabolic Disorders (2022) Vol. 21, Iss. 1, pp. 1081-1094
Open Access | Times Cited: 17
The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM)
Ousman Bajinka, Kodzovi Sylvain Dovi, Lucette Simbilyabo, et al.
Archives of Physiology and Biochemistry (2023) Vol. 130, Iss. 4, pp. 475-490
Closed Access | Times Cited: 11
Progress in the preparation and evaluation of glucose-sensitive microneedle systems and their blood glucose regulation
Yu Wang, Haojie Yu, Li Wang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 16, pp. 5410-5438
Closed Access | Times Cited: 11
The Effect of Probiotic Supplementation on Glucolipid Metabolism in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Rui Xiao, Linlin Wang, Peijun Tian, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3240-3240
Open Access | Times Cited: 11
Revealing the mechanism of quinoa on type 2 diabetes based on intestinal flora and taste pathways
Chun‐Yan Zheng, Tian An, Zheng‐Ting Liang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 12, pp. 7930-7945
Open Access | Times Cited: 11
Secondary failure of oral therapy in patients with type 2 diabetes: How to overcome it?
Aleksandra Marković, Tamara Dojčinović, Ivona Risović, et al.
SCRIPTA MEDICA (2025) Vol. 56, Iss. 1, pp. 93-98
Open Access
Nanotechnology in Diabetes Management: Advancements in PLGA-Based Drug Delivery
Saranya Balasubramaniyam, Thirumalaikumaran Rathinam, M. Srinivasan, et al.
Deleted Journal (2025)
Closed Access
Diabetes Management: Herbal Remedies and Emerging Therapies
Pratik Kumar Vishwakarma, Ankita Moharana, Snigdha Rani Behra, et al.
Current Nutraceuticals (2024) Vol. 05
Closed Access | Times Cited: 3
Isolation of Chalcomoracin as a Potential α-Glycosidase Inhibitor from Mulberry Leaves and Its Binding Mechanism
Yang Liu, Xue Zhou, Dan Zhou, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5742-5742
Open Access | Times Cited: 14
Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials
Lunwen Rao, Chenhong Ren, Shan Luo, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 7, pp. 869-880
Open Access | Times Cited: 17
Preparation, characterization and in vitro evaluation of chitosan nanoparticles for the oral delivery of GLP-1 analog liraglutide
Jeferson Ziebarth, Rubiana Mara Mainardes
Journal of Thermal Analysis and Calorimetry (2023) Vol. 148, Iss. 6, pp. 2443-2455
Closed Access | Times Cited: 6
Computational Approach to Elucidating Insulin–Protamine Binding Interactions and Dynamics in Insulin NPH Formulations
Ketan Kumar Rohilla, Manoj Kumar Pandey
ACS Omega (2024)
Open Access | Times Cited: 2
The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis
Luke Conroy, Alyssa McCann, Nan Zhang, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 5, pp. C1398-C1409
Closed Access | Times Cited: 2
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study
Elena A. Christofides, Orlando Puente, Paul Norwood, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2412-2421
Closed Access | Times Cited: 2
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges
Mahmoud Emad-Eldin, Gehan F. Balata, E el-Shorbagy, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 5, pp. 828-852
Open Access | Times Cited: 2
Efficacy of Regimens in the Treatment of Latent Autoimmune Diabetes in Adults: A Network Meta-analysis
Wanqing Wang, Fei Huang, Chunchao Han
Diabetes Therapy (2023) Vol. 14, Iss. 10, pp. 1723-1752
Open Access | Times Cited: 5
The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes
Edyta Sutkowska, Dominik Marciniak, Karolina Sutkowska, et al.
Endocrine (2022) Vol. 76, Iss. 2, pp. 273-281
Open Access | Times Cited: 8
Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems
Huiying Wang, Yunting Zhou, Yuming Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Ameliorative effects of chickpea flavonoids on redox imbalance and mitochondrial complex I dysfunction in type 2 diabetic rats
FU Ying-hua, Zhenglei Li, Shiqi Xiao, et al.
Food & Function (2022) Vol. 13, Iss. 17, pp. 8967-8976
Open Access | Times Cited: 7
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative
Annalisa Giandalia, Antonio Nicolucci, Michèle Modugno, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 2087-2096
Open Access | Times Cited: 1
Modern computational intelligence based drug repurposing for diabetes epidemic
Sweta Mohanty, Md. Harun Al Rashid, Chandana Mohanty, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102180-102180
Closed Access | Times Cited: 9
An overview of recent advances in insulin delivery and wearable technology for effective management of diabetes
Sujeet Kumar Raj, Molakpogu Ravindra Babu, Sukriti Vishwas, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103728-103728
Closed Access | Times Cited: 6
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
Gian Paolo Fadini, Olga Disoteo, Riccardo Candido, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 3, pp. 781-800
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top